Head-to-head comparison
MEDVidi vs Vytora Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
MEDVidi is a US telehealth platform whose licensed providers evaluate patients and prescribe GLP-1 weight-management medications, including brand-name Zepbound (tirzepatide) and Wegovy (semaglutide).
Marked down on: Consult-fee model: medication is not included and its cost is separate
Desk Score
Compounded semaglutide at $179 a month or $149 on a 3-month plan, tirzepatide at $249 or $199, plus brand Mounjaro and Zepbound at $1,399 a month — all-inclusive, no membership fee.
$179/mo sema · $249/mo tirz · Verified August 2026
Marked down on: Injectable only — no oral route
Vytora Health takes this head-to-head with the higher Desk Score, 89/100 (B+) against 52/100 (C) for MEDVidi. MEDVidi still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
MEDVidi
52/100
C
Vytora Health
89/100
B+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | MEDVidi | Vytora Health |
|---|---|---|
| Semaglutide | Not listed on MEDVidi's site (checked July 2026) | $179/mo$179/mo month-to-month; $149/mo on a 3-month plan ($447 every 3 months); same price at every dose; compounded injectable |
| Tirzepatide | Not listed on MEDVidi's site (checked July 2026) | $249/mo$249/mo month-to-month; $199/mo on a 3-month plan ($599 every 3 months); same price at every dose; compounded injectable |
| Coverage | Not listed on MEDVidi's site (checked July 2026) | All 50 states and DC |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Injectable only |
| Best for | People who want a licensed provider to prescribe brand glp-1 they fill with insurance. | Someone who wants a low compounded price without prepaying a year, and the option to move to brand tirzepatide on the same account. |
| Desk Score | 52/100C | 89/100B+ |
The verdict
Desk pick — Vytora HealthVytora Health takes this head-to-head with the higher Desk Score, 89/100 (B+) against 52/100 (C) for MEDVidi. MEDVidi still holds its ground where its strengths line up with yours.
Choose MEDVidi if…
People who want a licensed provider to prescribe brand glp-1 they fill with insurance.
Choose Vytora Health if…
Someone who wants a low compounded price without prepaying a year, and the option to move to brand tirzepatide on the same account.
$179/mo sema · $249/mo tirz · All 50 states and DC
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: MEDVidi · Vytora Health.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs MEDVidi
- CoreAge Rx vs Vytora Health
- Eden vs MEDVidi
- Ondra Health vs Vytora Health
- MEDVidi vs Pallas Health
- Sesame Care vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.